Great expectations: Developments and dynamics of a COVID-19 vaccine
The success of a COVID-19 vaccine is one of the biggest challenges we face globally. This paper explores the opportunities and obstacles that lie ahead.
Since the outbreak of COVID-19, the pharma industry has moved with unprecedented speed to progress vaccines through clinical trials safely, while simultaneously ramping up production on the chance of success.
As the world awaits news from these expedited clinical trials, however, we must also acknowledge that the task of vaccinating the world against COVID-19 won’t be easy – especially when it comes to bringing the public on side.
This paper uses Ipsos research to highlight the obstacles and opportunities that lie ahead – and the importance of building public support in determining any vaccine’s success.